ProfileGDS5678 / 1425564_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 58% 57% 58% 58% 57% 58% 57% 58% 58% 58% 65% 57% 57% 58% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.5326958
GSM967853U87-EV human glioblastoma xenograft - Control 23.4503957
GSM967854U87-EV human glioblastoma xenograft - Control 33.4847358
GSM967855U87-EV human glioblastoma xenograft - Control 43.4458458
GSM967856U87-EV human glioblastoma xenograft - Control 53.4136157
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.5678158
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.5231457
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4847958
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4642258
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4752458
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.9055865
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4350257
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4812957
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4851458